Evidence map›Paper›PMID 34283373›Full record

ReviewAmerican journal of clinical dermatology2021

Ceramides in Skin Health and Disease: An Update.

Yoshikazu Uchida, Kyungho Park

Abstract readReview
PubMed Publisher
In one paragraph

Review in American journal of clinical dermatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
6.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 129 citations in OpenAlex.

  1. Trial
  2. Effect of Rice (Nutrients · 2022
    Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Cells · 2026
    Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. The Role of Ceramides in Metabolic and Cardiovascular Diseases.Journal of cardiovascular development and disease · 2026
    Review
  14. Skin examination in extreme conditions.Acta biochimica Polonica · 2026
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Yoshikazu UchidaDepartment of Dermatology, School of Medicine, University of California, San Francisco, USA. Yoshikazu.Uchida@ucsf.edu.ORCID http://orcid.org/0000-0002-4980-3416
Kyungho ParkDepartment of Food Science and Nutrition, Convergence Program of Material Science for Medicine and Pharmaceutics, Hallym University, Chuncheon, 24252, Korea. kyungho.park@hallym.ac.kr.ORCID http://orcid.org/0000-0002-1552-9914
Hallym University · KRSan Francisco VA Medical Center · US

Funding

S1P-Mediated Stimulation of Antimicrobial DefenseR01AR062025 · NIAMS · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI HOLLERAN, WALTER M · 2012 to 2016
$1.6M
Ministry of Trade, Industry and Energy P0014701National Research Foundation of Korea 2018R1D1A1B7050504NIAMS NIH HHS R01 AR062025
6 · The paper itself

Abstract

Ceramides are a class of sphingolipid that is the backbone structure for all sphingolipids, such as glycosphingolipids and phosphosphingolipids. While being a minor constituent of cellular membranes, ceramides are the major lipid component (along with cholesterol, free fatty acid, and other minor components) of the intercellular spaces of stratum corneum that forms the epidermal permeability barrier. These stratum corneum ceramides consist of unique heterogenous molecular species that have only been identified in terrestrial mammals. Alterations of ceramide molecular profiles are characterized in skin diseases associated with compromised permeability barrier functions, such as atopic dermatitis, psoriasis and xerosis. In addition, hereditary abnormalities of some ichthyoses are associated with an epidermal unique ceramide species, omega-O-acylceramide. Ceramides also serve as lipid modulators to regulate cellular functions, including cell cycle arrest, differentiation, and apoptosis, and it has been demonstrated that changes in ceramide metabolism also cause certain diseases. In addition, ceramide metabolites, sphingoid bases, sphingoid base-1-phosphate and ceramide-1-phosphate are also lipid mediators that regulate cellular functions. In this review article, we describe diverse physiological and pathological roles of ceramides and their metabolites in epidermal permeability barrier function, epidermal cell proliferation and differentiation, immunity, and cutaneous diseases. Finally, we summarize the utilization of ceramides as therapy to treat cutaneous disease.

Indexed as

AnimalsCell DifferentiationCell ProliferationCeramidesEpidermisHumansLipid MetabolismPermeabilitySkin DiseasesCeramides

Identifiers

PMID34283373
OpenAlexW3183399405

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.